Circassia group plc
WebJul 14, 2024 · Circassia Group is not a large company by global standards. It has a market capitalization of UK£134m, which means it wouldn't have the attention of many … WebMar 31, 2024 · NIOX Group plc, formerly Circassia Group plc, is a United Kingdom-based diagnostics and management company focused on asthma. The Company’s product NIOX uses patented technology to measure fractional exhaled nitric oxide (FeNO). Its NIOX FeNO measurement and monitoring products are used by physicians around the globe to …
Circassia group plc
Did you know?
WebDec 30, 2024 · Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products. The UK£166m market-cap company posted a loss in its most recent financial year of UK ... WebAbout NIOX Group plc; Company profile; Board of directors; Company scientific advisor; Management team; Corporate responsibility; Products. Our products; Product contacts; … Asthma and airway inflammation. Asthma is a common lung disease affecting nearly … Oxford, UK – 16 June 2024: Circassia Group plc (“Circassia” or “the … Contacts - Circassia - NIOX Group plc: The leading provider of point-of-care FeNO ... Michael Roller. Chief Financial Officer ... ... Tom Scaccia. Senior Vice President Americas and Research Business ... ... NIOX recognizes the importance of corporate social responsibility, and … Regulatory news - Circassia - NIOX Group plc: The leading provider of point-of-care … Share price chart - Circassia - NIOX Group plc: The leading provider of point-of-care …
WebSep 19, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Circassia Group Plc Executive Chairman, Ian Johnson, recently bought UK£56k worth … WebCircassia is a dedicated diagnostics and monitoring company focused on respiratory disease. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and …
WebLegal Name Circassia Group PLC; Stock Symbol LSE:CIR ; Company Type For Profit; Contact Email [email protected]; Phone Number +4401865405560; Circassia is a dedicated diagnostics and … WebJul 13, 2024 · Circassia Group plc First Half Trading Update. Business strategy drives H1 revenue and profit growth Oxford, UK - 13 July 2024: Circassia Group plc ("Circassia" or "the Company"; LSE: CIR), a medical device company focused on point of care asthma diagnosis and management, today announces a trading update for the six months ended …
Circassia Group PLC is a company focussed on treating people suffering from respiratory diseases through its NIOX (Nitric Oxide) range of FeNO (Fractional Exhaled Nitric Oxide) devices which help diagnose and manage asthma. The company is a provider of point-of-care FeNO (Fractional Exhaled Nitric Oxide) measurement and monitoring. It is listed on the London Stock Exchange.
WebCompany profile page for Circassia Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information high seat folding camping chairsWebNIOX® devices have been used for many years for FeNO-guided asthma management. In 2013 and 2014, studies using NIOX® devices showed up to a 50% reduction in exacerbations in both adults and children. 13,14. More recently in 2024, NIOX® technology helped show that FeNO is a strong predictor of exacerbations, as FeNO levels ≥25 ppb … high seat holdings ltdhow many days a runner should yogaWebCircassia Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker CIR. The last closing price for Circassia was 34p. Circassia Group Plc has a 4 week average price of 0p and a 12 week average price of 0p. The 1 year high share price is 41.50p while the 1 year low share price is currently 29p. high seat hillWebJun 16, 2024 · Oxford, UK – 16 June 2024: Circassia Group plc (“Circassia” or “the Company”) (LSE: CIR) today announces its preliminary results for the year ended 31 December 2024 and a post-period update. Financial progress. Key performance indicators £m: 2024 underlying continuing operations: 2024 underlying continuing operations: 2024 … high seat holdings limitedWebJul 15, 2024 · Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of … high seat garden furnitureWebCircassia Group Plc (Circassia), formerly Circassia Pharmaceuticals plc, is a medical device company that develops and manufactures drugs for the treatment of allergy and … how many days a period last